Article
San Diego-The Amadeus microkeratome (AMO) produces consistent flaps and offers a number of variables that can be controlled by surgeons, noted Robert Weinstock, MD.
Iantrek announces positive 2-year results from clinical study of its bio-interventional platform for uveoscleral outflow enhancement
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Ocugen to move forward with dosing of second cohort of phase 1 clinical trial of OCU200
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Stem cell-based CALEC therapy achieves 90% corneal surface restoration in clinical trial
Investigators highlight the risk of misdiagnosing geographic atrophy